company

ACTIVE PHARMA AS

1555 SON

Finances

Share Ownership

Return on Equity

−37,08 %

Current Ratio

0,75

Debt-to-Equity Ratio

−0,77

Key figures (NOK)	2022	2021	2020	2019
Revenue	671 000	1 506 000	2 322 000	661 000
Net Income	66 000	464 000	−267 000	−668 000
Total Assets	123 000	217 000	555 000	577 000
Total Equity	−178 000	−377 000	−841 000	−574 000

Income (NOK)	2022	2021	2020	2019
Revenue	671 000	1 506 000	2 322 000	661 000
Expenditure	641 000	998 000	2 526 000	1 299 000
Operating Profit	29 000	508 000	−204 000	−638 000
Financial Income	0	2 000	1 000	0
Financial Costs	−36 000	46 000	64 000	30 000
Financial Balance	36 000	−44 000	−63 000	−30 000
Earnings Before Tax	66 000	464 000	−267 000	−668 000
Tax	0	0	0	0
Net Income	66 000	464 000	−267 000	−668 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	0	0	0	0
Total Current Assets	123 000	217 000	555 000	577 000
Total Assets	123 000	217 000	555 000	577 000
Total Retained Equity	−272 000	−471 000	−935 000	−668 000
Total Equity	−178 000	−377 000	−841 000	−574 000
Total Long-Term Debt	137 000	295 000	700 000	708 000
Total Current Debt	164 000	300 000	695 000	443 000
Total Equity and Debt	123 000	217 000	555 000	577 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	623 000	1 489 000	2 285 000	652 000
Other Income	48 000	17 000	37 000	9 000
Revenue	671 000	1 506 000	2 322 000	661 000
Cost of Goods Sold	97 000	106 000	389 000	204 000
Salary Costs	420 000	625 000	680 000	0
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	641 000	998 000	2 526 000	1 299 000
Operating Profit	29 000	508 000	−204 000	−638 000
Financial Income	0	2 000	1 000	0
Financial Costs	−36 000	46 000	64 000	30 000
Financial Balance	36 000	−44 000	−63 000	−30 000
Dividends	0	0	0	0
Net Income	66 000	464 000	−267 000	−668 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	0	0	0	0
Stock	0	97 000	203 000	341 000
Total Investments	0	0	0	0
Cash, Bank	119 000	92 000	229 000	78 000
Total Current Assets	123 000	217 000	555 000	577 000
Total Assets	123 000	217 000	555 000	577 000
Total Equity	−178 000	−377 000	−841 000	−574 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	137 000	295 000	700 000	708 000
Creditors	18 000	38 000	32 000	139 000
Unpaid Taxes	33 000	55 000	64 000	0
Dividends	0	0	0	0
Other Current Debt	112 000	206 000	599 000	304 000
Total Current Debt	164 000	300 000	695 000	443 000
Total Equity and Debt	123 000	217 000	555 000	577 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−37,08 %	−123,08 %	31,75 %	116,38 %
Debt-to-Equity Ratio	−0,77	−0,78	−0,83	−1,23
Operating Profit Margin	4,32 %	33,73 %	−8,79 %	−96,52 %
Current Ratio	0,75	0,72	0,8	1,3
Quick Ratio	0,75	1,07	1,13	5,66
Equity Ratio	−1,45	−1,74	−1,52	−0,99
Gross Profit Margin	85,54 %	92,96 %	83,25 %	69,14 %

Rotate your device to see the full table

Home Industries New Companies About

🇳🇴Norsk 🇬🇧English